Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE21-006: Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting, 32934 [2021-13121]

Download as PDF 32934 Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices vaccine, dengue vaccine, ebola vaccine, hepatitis vaccines, herpes zoster vaccines, influenza vaccines, orthopoxvirus vaccine, pneumococcal vaccine, rabies vaccine and tickborne encephalitis vaccine. Recommendation votes on dengue vaccine, ebola vaccine, influenza vaccines and rabies vaccine are scheduled. Vaccines for Children (VFC) votes on dengue vaccine and influenza vaccines are scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https:// www.cdc.gov/vaccines/acip/meetings/ meetings-info.html. Meeting Information: The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http:// www.cdc.gov/vaccines/acip/index.html. jbell on DSKJLSW7X2PROD with NOTICES Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. Procedure for Oral Public Comment: All persons interested in making an oral public comment at the June 23–25, 2021, ACIP meeting must submit a request at http://www.cdc.gov/vaccines/ acip/meetings/ no later than 11:59 p.m., VerDate Sep<11>2014 17:13 Jun 22, 2021 Jkt 253001 EDT, June 18, 2021, according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by June 21, 2021. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting. Written Public Comment: The docket will be opened to receive written comments on June 1, 2021. Written comments must be received on or before June 25, 2021. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–13120 Filed 6–22–21; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE21–006: Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE21– 006: Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA); July 13–14, 2021, 8:30 a.m.–5:00 p.m., EDT. The videoconference meeting was published in the Federal Register on March 29, 2021, Volume 86, Number 58, page 16369. The meeting is being amended to update the contact person and should read as follows: Frm 00053 Fmt 4703 Aisha Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone: (404) 639–6473; Email: awilkes@ cdc.gov. The meeting is closed to the public. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–13121 Filed 6–22–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: BILLING CODE 4163–18–P PO 00000 FOR FURTHER INFORMATION CONTACT: Sfmt 4703 In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC). This meeting is partially open to the public. There will be 15 minutes allotted for public comments at the end of the open session from 11:40 a.m., to 11:55 p.m., EDT. DATES: The meeting will be held on July 29, 2021, from 10:00 a.m. to 12:00 p.m., EDT (OPEN); and from 12:30 p.m., to 4:15 p.m., EDT (CLOSED). ADDRESSES: Open Session: Webinar, Atlanta, Georgia. All participants must register using the link provided to attend the open meeting: https:// dceproductions.zoom.us/webinar/ register/wn_cz3nu0zfsg29fiojefau8q. Closed Session: Teleconference. FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, SUMMARY: E:\FR\FM\23JNN1.SGM 23JNN1

Agencies

[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Page 32934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13121]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE21-006: Rigorously Evaluating Programs and 
Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE21-006: Rigorously Evaluating Programs and Policies to Prevent 
Child Sexual Abuse (CSA); July 13-14, 2021, 8:30 a.m.-5:00 p.m., EDT.
    The videoconference meeting was published in the Federal Register 
on March 29, 2021, Volume 86, Number 58, page 16369.
    The meeting is being amended to update the contact person and 
should read as follows:

FOR FURTHER INFORMATION CONTACT: Aisha Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, CDC, 
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, 
Telephone: (404) 639-6473; Email: [email protected].
    The meeting is closed to the public.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-13121 Filed 6-22-21; 8:45 am]
BILLING CODE 4163-18-P